Früherkennung bei Brustkrebs

Breast cancer is the most common cancer and the most common cause of cancer-related death in women in Germany. For women with a normal risk of breast cancer surveillance for early detection starts from the age of 30 years. Since 2004, women between the age of 50–69 years have the possibility to participate in a systematic and population-based mammography screening. Benefits and harms of mammography screening are currently subject to controversy. Results concerning mortality reduction from the German mammography screening program are to be expected from 2018. It seems quite possible that a further development of digital mammography, tomosynthesis, will soon be introduced. For women with an increased risk for breast cancer due to genetic change (BRCA1 and BRCA2 mutations), an intensified surveillance for early breast cancer detection is available beginning from the age of 25 years or 5 years before the earliest disease onset of the relative (ultrasound, MRI, mammography).